Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.

C. Yap(UCLA Medical Center), Johannes Czernin(University of California, Los Angeles), Marc Seltzer(University of California, Los Angeles), Peter E. Valk(University of California, Los Angeles), Michael E. Phelps(National Academy of Engineering), Jyotsna Rao, Christiaan Schiepers, Sanjiv S. Gambhir(Stanford University)
PubMed
September 1, 2001
Cited by 114

Related Papers

Molecular imaging in living subjects: seeing fundamental biological processes in a new light
|Genes & Development|2003|2.2k
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
|Science|2004|1.1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
|Proceedings of the National Academy of Sciences|2000|798